Geter-Douglass B, Riley A L
Psychobiology Section, NIDA Division of Intramural Research, Baltimore, MD 21224, USA.
Pharmacol Biochem Behav. 1996 Jun;54(2):439-51. doi: 10.1016/0091-3057(95)02217-1.
Although data suggest that the dopaminergic system mediates the discriminative stimulus effects of cocaine, neither selective D1 or D2 dopamine agonists nor selective D1 or D2 antagonists substitute reliably for or consistently block these effects. These findings suggest that concurrent activity at these receptor subtypes may underlie this discrimination. Accordingly, it would be expected that simultaneous blockade of these receptors may be necessary to block it fully. The ability of various combinations of the D1 antagonist, SCH 23,390, and the D2 antagonist, haloperidol, were tested for their ability to block the cocaine stimulus in rats trained to discriminate cocaine (7.5, 10, or 13 mg/kg) from vehicle. Antagonist combinations decreased the percentage of cocaine-appropriate responses 10-95% below the cocaine baseline at doses of the antagonist that were inactive when given separately. These findings support the position that activity at D1-like and D2-like receptor subtypes may account for more of the pharmacological action of cocaine than activation of a single dopamine receptor subtype.
尽管数据表明多巴胺能系统介导了可卡因的辨别刺激效应,但无论是选择性D1或D2多巴胺激动剂,还是选择性D1或D2拮抗剂,都不能可靠地替代或持续阻断这些效应。这些发现表明,这些受体亚型的同时活动可能是这种辨别作用的基础。因此,可以预期,同时阻断这些受体可能是完全阻断它所必需的。测试了D1拮抗剂SCH 23,390和D2拮抗剂氟哌啶醇的各种组合阻断训练来辨别可卡因(7.5、10或13mg/kg)与赋形剂的大鼠中可卡因刺激的能力。拮抗剂组合在单独给药时无活性的拮抗剂剂量下,使可卡因适宜反应的百分比比可卡因基线降低了10 - 95%。这些发现支持这样一种观点,即与单一多巴胺受体亚型的激活相比,D1样和D2样受体亚型的活动可能在可卡因的药理作用中占更大比例。